Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Ezetimibe / Atorvastatin

Australian Public Assessment Report

AusPAR

AusPAR: Ezetimibe / Atorvastatin [PDF, 612.34 KB]

AusPAR: Ezetimibe / Atorvastatin [Word, 685.25 KB]

Attachment: Product information: Ezetimibe / Atorvastatin [PDF, 372.73 KB]

Attachment: Product information: Ezetimibe / Atorvastatin [Word, 399.5 KB]

Attachment: Extract from Clinical Evaluation Report for Ezetimibe / Atorvastatin [PDF, 1.3 MB]

Attachment: Extract from Clinical Evaluation Report for Ezetimibe / Atorvastatin [Word, 3.52 MB]

Device/Product Name

Atozet / Zeteze

Active ingredients

Ezetimibe / Atorvastatin

AusPAR Date

11 July 2017

Published

15 August 2017

Submission Number

PM-2015-04334-1-3

Submission Type

Extension of indications

Decision

Approved